Genotype in the 24-kDa subunit gene (NDUFV2) of mitochondrial complex I and susceptibility to Parkinson disease

Genomics

Volumn 49, Issue 1, 1998, Pages 52-58

  Hattori, Nobutaka ^a   Yoshino, Hiroyo ^a   Tanaka, Masashi ^b   Suzuki, Hiroshi ^c   Mizuno, Yoshikuni ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU INTERNATIONAL INSTITUTE OF BIOTECHNOLOGY   (Japan)

^c FUKUI PREFECTURAL UNIVERSITY   (Japan)

Author keywords

24 kDa subunit; Complex I; Genetic predisposition; Mitochondria; Parkinson disease

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0032054295     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1997.5192     Document Type: Article

References (49)

1. Armstrong M., Daly A. K., Cholerton S., Bateman D. N., Idle J. R. Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet. 339:1992;1017-1018.
2. Calne D. B., Langston J. W. Aetiology of Parkinson's disease. Lancet. ii:1983;1457-1459.
3. Calne D. B., Snow B. J., Lee C. Criteria for diagnosing Parkinson's disease. Ann. Neurol. 1992;S125-S127.
4. Chou P. Y., Fasman G. D. Prediction of protein conformation. Biochemistry. 13:1974;222-245.
5. de Coo R., Buddiger P., Smeets H., van Kessel A. G., Morgan-Hughes J., Weghuis D. O., Overhauser J. Molecular cloning and characterization of the active human mitochondrial NADH:ubiquinone oxidoreductase 24-kDa gene (NDUFV2) and its pseudogene. Genomics. 26:1995;461-466.
6. Dexter D. T., Carayon A., Vidailhet M., Ruberg M., Javoy-Agid F., Agid Y., Lees A. J. Decreased ferritin levels in brain in Parkinson's disease. J. Neurochem. 55:1990;16-20.
7. Dexter D. T., Carter C. J., Wells F. R., Javoy-Agid F., Agid Y., Lees A., Jenner P. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52:1989;381-389.
8. Good P. F., Olanow C. W., Perl D. P. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminium in Parkinson's disease: A LAMMA study. Brain Res. 593:1992;343-346.
9. Grantham R. Amino acid difference formula to help explain protein evolution. Science. 185:1974;862-864.
10. Hattori N., Suzuki H., Wang Y., Minoshima S., Shimizu N., Yoshino H., Kurashima R. Structural organization and chromosomal localization of the human nuclear gene (NDUFV2) for the 24-kDa iron-sulfur subunit of complex I in mitochondrial respiratory chain. Biochem. Biophys. Res. Commun. 216:1995;771-777.
11. Hattori N., Tanaka M., Ozawa T., Mizuno Y. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. Ann. Neurol. 30:1991;563-571.
12. Ho S. L., Kapadí A. L., Ramsden D. B., Williams A. C. An allelic association study of monoamine oxidase B in Parkinson's disease. Ann. Neurol. 37:1995;403-405.
13. Hotamisligil G. S., Girmen A. S., Fink J. S., Tivol E., Shalish C., Tfofatter J., Baenzinger J. Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease. Mov. Disord. 9:1994;305-310.
14. Ikebe S., Tanaka M., Ozawa T. Point mutations of mitochondrial genome in Parkinson's disease. Mol. Brain Res. 28:1995;281-295.
15. Jellinger K., Kienzl E., Rumpelmair G., Riederer P., Atachelberger H., Ben-Shachar D., Youdim M. H. B. Iron-melanin complex in substantia nigra parkinsonian brains: An X-ray microanalysis. J. Neurochem. 59:1992;1168-1171.
16. Jenner P., Dexter D. T., Sian J., Schapira A. H. V., Marsden C. D. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. Ann. Neurol. 32:1992a;82-87.
17. Jenner P., Schapira A. H., Marsden C. D. New insights into the cause of Parkinson's disease. Neurology. 42:1992b;2241-2250.
18. Kondo I., Kanazawa I. Association of Xba I allele (Xba I 44kb) of the human cytochrome P-450 (CYP2D6) gene in Japanese patients with idiopathic Parkinson's disease. Parkinson's Disease: From Clinical Aspects to Molecular Basis. 1991;Springer-Verlag, Vienna. p. 111-117.
19. Kurth J. H., Kurth M. C., Poduslo S. E., Schwankhaus J. D. Association of a monoamine oxidase B allele with Parkinson's disease. Ann. Neurol. 33:1993;368-372.
20. Kurth M. C., Kurth J. H. Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease. Am. J. Med. Genet. 48:1993;166-168.
21. Kyte J., Doolittle R. F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:1982;105-132.
22. Langston J. W. Current theorities on the cause of Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 52:1989;13-17.
23. Marttila R. J., Lorentz H., Rinne U. K. Oxygen toxicity protecting enzymes in Parkinson's disease: Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus. J. Neurol. Sci. 86:1988;321-331.
24. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
25. Mizuno Y., Ikebe S., Hattori N., Nakagawa H. Y., Mochizuki H., Tanaka M., Ozawa T. Role of mitochondria in the etiology and pathogenesis of Parkinson's disease. Biochim. Biophys. Acta. 1271:1995;265-274.
26. Mizuno Y., Matsuda S., Yoshino H., Mori H., Hattori N., Ikebe S. An immunohistochemical study on α-ketoglutarate dehydrogenase complex in Parkinson's disease. Ann. Neurol. 35:1994.
27. Mizuno Y., Ohta S., Tanaka M., Takamiya S., Suzuki K., Sato T., Oya H. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 163:1989;1450-1455.
28. Morimoto Y., Murayama N., Kuwano A., Kondo I., Yamashita Y., Mizuno Y. Association analysis of a polymorphism of the monoamine oxidase B gene with Parkinson's disease in a Japanese population. Am. J. Med. Genet. 60:1995;570-572.
29. Nishikimi M., Hosokawa Y., Toda H., Suzuki H., Ozawa T. The amino acid sequence of the 24-kDa subunit, an iron-sulfur protein, of rat liver mitochondrial NADH dehydrogenase deduced from cDNA sequence. Biochem. Biophys. Res. Commun. 157:1988;914-920.
30. Ohnishi T., Ragan C. I., Hatefi Y. EPR studies of iron-sulfur clusters in isolated subunits and subfractions NADH-ubiquinone oxidoreductase. J. Biol. Chem. 260:1985;2782-2788.
31. Payami H., Larsen K., Bernard S., Nutt J. Increased risk of Parkinson's disease in parents and siblings of patients. Ann. Neurol. 36:1994;659-661.
32. Pilkington S. J., Skehel J. M., Gennis R. B., Walker J. E. Relationship between mitochondrial NADH-ubiquinone reductase and a bactarial NAD-reducing hydrogenase. Biochemistry. 30:1991;2166-2175.
33. Pilkington S. J., Walker J. E. Mitochondrial NADH-ubiquinone reductase: Complementary DNA sequences of import precursors of the bovine and human 24-kDa subunit. Biochemistry. 28:1989;3257-3264.
34. Rajput A. H., Uitti R. J., Stern W., Laverty W., O'Donnell K., O'Donnell D., Yuen W. K. Geography, drinking water chemistry, pesticides and herbicides and the etiology of Parkinson's disease. Can. J. Neurol. Sci. 14:1987;414-418.
35. Riederer P., Sofic E., Rausch W. D., Schmidt B., Reynolds G. P., Jellinger K., Youdim M. B. H. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 55:1989;515-520.
36. Saggu H., Cooksey J., Dexter D., Wells F. R., Lees A., Jenner P., Marsden C. D. A selective increase in particulate superoxide dismutase activity in parkinsonian sunstantia nigra. J. Neurochem. 53:1989;692-697.
37. Schapira A. H., Cooper J. M., Dexter D., Jenner P., Clark J. B., Marsden C. D. Mitochondrial complex I deficiency in Parkinson's disease. Lancet. 1:1989;1269.
38. Schapira A. H., Mann V. M., Cooper J. M., Dexter D., Daniel S. E., Jenner P., Clark J. B. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 55:1990;2142-2145.
39. Shimoda-Matsubayashi S., Matsumine H., Kobayashi T., Nakagawa-Hattori Y., Shimizu Y., Mizuno Y. Identification of dimorphic muattion in the mitochondrial targeting sequence in the human MnSOD gene and its allelic association with Parkinson's disease. Biochem. Biophys. Res. Commun. 226:1996;561-565.
40. Shoffner J. M., Brown M. D., Torroni A., Lott M. T., Cabell M. F., Mirra S. S., Beal M. F. Mitochondrial DNA variations observed in Alzheimer disease and Parkinson disease patients. Genomics. 17:1993;171-184.
41. Sjoling S., Eriksson A. C., Glaser E. A helical element in the C-terminal domain of theN. plumbaginifolia. J. Biol. Chem. 269:1994;32059-32062.
42. Smith C. A., Gough A. C., Leigh P. N., Summers B. A., Harding A. E., Maranganore D. M., Sturman S. G. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet. 339:1992;1375-1377.
43. Toda H., Hosokawa Y., Nishikimi M., Suzuki H., Kato K., Ozawa T. Cloning and sequencing of cDNA encoding the precursor to the 24 kDa iron-sulfur protein of human mitochondrial NADH dehydrogenase. Int. J. Biochem. 21:1989;1161-1168.
44. Tran-Betcke A., Warnecke U., Böcker C., Zaborosch C., Friedrich B. Cloning and nucleotide sequences of the genes for the subunits of NAD-reducing hydrogenase ofAlcaligenes eutrophus. J. Bacteriol. 226:1990;1051-1072.
45. Tsuneoka Y., Matsuno Y., Iwasaki K., Takeuchi H., Ichikawa Y. A novel cytochrome P-450IID6 gene associated with Parkinson's disease. J. Biochem. 114:1993;263-266.
46. von Heijne G., Steppuhn J., Herrmann R. G. Domain structure of mitochondrial and chloroplast targeting peptides. Eur. J. Biochem. 180:1989;535-545.
47. Walker J. E., Arizmendi J. M., Dupuis A., Fearnley I. M., Finel M., Medd S. M., Pilkington S. J. Sequences of 20 subunits of NADH:ubiquinone oxidoreductase from bovine heart mitochondria. Application of a novel strategy for sequencing proteins using the polymerase chain reaction. J. Mol. Biol. 226:1992;1051-1072.
48. Wilhelmsen K. C., Wszollek Z. K. Is there a genetic susceptibility to idiopathic Parkinsonism. Parkinsonism Rel. Disorders. 1:1995;73-84.
49. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E. R., Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. USA. 93:1996;2696-2701.